CytoSorbents Provides DrugSorb-ATR Regulatory Update
Provided By PR Newswire
Last update: Sep 16, 2025
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on DrugSorb™-ATR.
Read more at prnewswire.comNASDAQ:CTSO (11/26/2025, 8:24:49 PM)
0.791
-0.05 (-5.47%)
Find more stocks in the Stock Screener
CTSO Latest News and Analysis
13 days ago - By: Chartmill
